Search
Displaying 851–860 of 865 results for “vision connection”
-
Stem-Cell Therapy Clinics Remain Inadequately Regulated, Pose Risk to Patients
Research NewsIf a clinic is charging for a stem-cell treatment or procedure for an IRD, it is probably not legit. The expense to the patient is a major red flag.
-
Twelve People Receive XLRS Gene Therapy in AGTC's Clinical Trial
Research NewsAGTC’s gene therapy uses a human-engineered virus — and adeno-associated virus or AAV — to deliver normal copies of retinoschisin to the patient’s retina.
-
FFB Funding Helps Retinal Genetics Lab Secure $2 Million Investment
Research NewsHow the Foundation Fighting Blindness (FFB) provided timely funding of $155,000 to help a lab at the University of California, San Diego (UCSD), leverage a $2 million retinal-gene discovery project.
-
AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials
Research NewsCompany Builds on FFB’s Initial Investment to Garner $265 Million in Therapy Development Funding
-
Two Philanthropic Brothers — Selling Luxury Casual Wear for the Good of Retinal Research
Beacon StoriesThe story of Two Blind Brothers, a luxury clothing line that donates its proceeds to retinal research.
-
Two Philanthropic Brothers — Selling Luxury Casual Wear for the Good of Retinal Research
Research NewsThe story of Two Blind Brothers, a luxury clothing line that donates its proceeds to retinal research.
-
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
Foundation NewsDavid Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In the PressIn a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
-
Changing Someone’s Life: A New Video Emphasizes the Need to Support FFB’s Mission
Beacon StoriesAllison Corona is one of 40 people with Leber congenital amaurosis who’ve benefitted from a gene therapy clinical trial.
-
Foundation Chairman, Gordon Gund, Interviewed on Forbes.com
Beacon StoriesThe driving force behind the Foundation’s considerable advances covers those, as well as other compelling subjects, during a 27-minute Q&A.
